Basic information

Biomarker: MMP-9 

Histology type: endometrial carcinoma

Cohort characteristics

Country: Germany

Region:  Kiel

Followed up time :

Total number Group I Group I number Group II Group II number Group III Group III number Group IV Group IV number
97 tissues of peritoneal endometriosis, endometriosis of the intestine and endometrial carcinoma

Sample information

Conclusion: There are obvious differences in expression patterns of MMP-9 in different stages of endometriosis and in endometrial cancer. 

Sample type : tissue

Sample method: immunohistochemisty

Expression pattern : expression

Expression elevation: Staining intensity (SI) was multiplied by the percentage of positive cells (PP) gaining a score between 0 and 12. PP considered 5 groups: >80% of positive (four points), 51–80% positive cells (three points), two points for 10–50%, one point for <10% and zero points if no positive cells could be detected. Staining intensity ranged from no reaction = 0 points, slightly stained = 1 point, moderately stained = 2 points and strongly stained = 3 points. A score >3 was evaluated as a positive reaction and 9 points as strongly positive.

Disease information

Related information

Funtion Uniprot: Matrix metalloproteinase that plays an essential role in local proteolysis of the extracellular matrix and in leukocyte migration (PubMed:2551898, PubMed:1480034, PubMed:12879005). Could play a role in bone osteoclastic resorption (By similarity). Cleaves KiSS1 at a Gly-|-Leu bond (PubMed:12879005). Cleaves NINJ1 to generate the Secreted ninjurin-1 form (PubMed:32883094). Cleaves type IV and type V collagen into large C-terminal three quarter fragments and shorter N-terminal one quarter fragments (PubMed:1480034). Degrades fibronectin but not laminin or Pz-peptide

UniProt ID: P14780

UniProt Link: https://www.uniprot.org/uniprotkb/P14780/entry

Biological function from UniProt: #Collagen degradation

Molecular function from UniProt:

Tissue specificity from UniProt: Detected in neutrophils (at protein level) (PubMed:7683678). Produced by normal alveolar macrophages and granulocytes

Subcellular UniProt: #Extracellular matrix #Secreted

Alternative name from UniProt:

Cleaved: Cleaved into 2 chains 67 kDa matrix metalloproteinase-9 82 kDa matrix metalloproteinase-9

Miscellaneous: In the arthritis patient this enzyme might contribute to the pathogenesis of joint destruction and might constitute a useful marker of disease status.

Catalytic activity: Cleavage of gelatin types I and V and collagen types IV and V.

Activity regulation: Inhibited by histatin-3 1/24 (histatin-5). Inhibited by ECM1.

Recommended name: Matrix metalloproteinase-9

Gene name from HGNC: MMP9 (CLG4B)

HPA class: Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Human disease related genes Plasma proteins

AlphaFold DB: P14780

AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P14780

Induction: Activated by 4-aminophenylmercuric acetate and phorbol ester. Up-regulated by ARHGEF4, SPATA13 and APC via the JNK signaling pathway in colorectal tumor cells. (Microbial infection) Expression induced by M.bovis MPB83 (at protein level) (PubMed:20800577).

HPA link: https://www.proteinatlas.org/ENSG00000100985-MMP9

Tissue specificity RNA from HPA: Group enriched (bone marrow, lymphoid tissue)

Tissue expression from HPA: Selective nuclear and cytoplasmic expression in a subset of immune cells in several tissues, including lymphoid organs, and hematopoietic cells.

Single cell type specificity Group enriched (Langerhans cells, Hofbauer cells, Macrophages)

Immune cell specificity: Immune cell enriched (neutrophil)

Subcellular summary HPA Located in Cytosol

Cancer prognostic summary HPA Prognostic marker in renal cancer (unfavorable), endometrial cancer (favorable) and liver cancer (unfavorable)

Pathology link: https://www.proteinatlas.org/ENSG00000100985-MMP9/pathology

Pathology endo: https://www.proteinatlas.org/ENSG00000100985-MMP9/pathology/endometrial+cancer

Phenotype ID: 03932;613073;

Disease: Intervertebral disc disease (IDD);Metaphyseal anadysplasia 2 (MANDP2);

Note1: Disease susceptibility is associated with variants affecting the gene represented in this entry;The disease is caused by variants affecting the gene represented in this entry;

Note2: A number sign (#) is used with this entry because of evidence that variations in many genes are involved in susceptibility to intervertebral disc disease. See MOLECULAR GENETICS section.;A number sign (#) is used with this entry because of evidence that metaphyseal anadysplasia-2 (MANDP2) is caused by homozygous mutation in the gene encoding matrix metalloproteinase-9 (MMP9; 120361) on chromosome 20q13. For a general phenotypic description and a discussion of genetic heterogeneity of metaphyseal anadysplasia, see MANDP1 (602111).;

OMIM: 120361;603932;613073;

OMIM link1: https://www.omim.org/entry/603932;https://www.omim.org/entry/613073;

OMIM link2: https://www.omim.org/entry/120361;https://www.omim.org/entry/613073;

Phenotype: INTERVERTEBRAL DISC DISEASE;METAPHYSEAL ANADYSPLASIA 2;

HGNC ID: HGNC:7176

HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:7176

Visulization